Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Exercise of Options

2 Mar 2016 14:05

RNS Number : 8264Q
Pressure Technologies PLC
02 March 2016
 

 

2 March 2016

 

Exercise of Options / Issue of Equity

 

Pressure Technologies plc ("the Company") announces that it has issued and allotted 50,600 new ordinary shares of 5p each in the Company, following an exercise of options pursuant to the Company's SAYE scheme. The 50,000 options were exercised at a price of 150.5 pence per share and 600 were exercised at a price of 150 pence per share.

 

The new ordinary shares will rank pari passu with existing ordinary shares in the Company and application has been made for these new ordinary shares to be admitted to trading on AIM, which is expected to occur on or around 8 March 2016.

 

Total Voting Rights

 

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 5 pence of Pressure Technologies in issue at the date of this notice is 14,471,295.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Pressure Technologies, under the Disclosure and Transparency Rules.

 

For further information, please contact:

Pressure Technologies plc

Keeley Clarke, Investor Relations

Tel: 0114 257 3616

www.pressuretechnologies.com

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

Philip Davies / Will Goode

Tel: 020 7149 6942

 

COMPANY DESCRIPTION

 

Company description - www.pressuretechnologies.com

 

With its head office in Sheffield, Pressure Technologies was founded on its leading market position as a designer and manufacturer of high pressure systems serving the global energy, defence and industrial gases markets. Today it continues to serve those markets from a broader engineering base with specialist precision engineering businesses and has a worldwide presence in Alternative Energy as the global leader in biogas upgrading. On this foundation, the company is building a highly profitable group of companies through a combination of organic initiatives and acquisitions.

 

Pressure Technologies has four divisions, Precision Machined Components, Cylinders, Engineered Products and Alternative Energy, serving four markets: oil and gas, defence, industrial gases and alternative energy.

 

Precision Machined Components

· Al-Met, Mid Glamorgan, acquired in 2010 www.almet.co.uk

· Roota Engineering, Rotherham, acquired in March 2014 www.roota.co.uk

· Quadscot, Glasgow, acquired in October 2014 www.quadscot.co.uk

 

Cylinders

· Chesterfield Special Cylinders, Sheffield, IPO cornerstone in 2007 www.chesterfieldcylinders.com

· Kelley GTM Manufacturing, Amarillo - 40% stake acquired by the Group in December 2013 www.kelleygtm.com

 

Engineered Products

· Hydratron, Manchester and Houston, acquired in 2010 www.hydratron.com

 

Alternative Energy

· Chesterfield BioGas, Sheffield, founded in 2008. Renamed Greenlane Biogas UK on 5 June 2015.

· Greenlane, Vancouver, Canada and Auckland, New Zealand, acquired in October 2014 www.greenlanebiogas.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEALDAEELKEFF
Date   Source Headline
20th Mar 202512:02 pmRNSResults of 2025 Annual General Meeting
20th Mar 20257:00 amRNS2025 Annual General Meeting & Trading Update
19th Mar 20257:00 amRNSHydrogen Storage Contract Placement
5th Mar 20252:30 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSNotice of Annual General Meeting
5th Feb 20257:20 amRNS2024 Full-Year Results
5th Feb 20257:00 amRNSProposed Change of Name and TIDM
28th Jan 20257:00 amRNSNotice of Results and Investor Presentation
28th Jan 20257:00 amRNSDefence Contract Placement
1st Nov 202412:00 pmRNSBoard Change
1st Nov 202410:38 amRNSPDMR / PCA Shareholding
24th Oct 20247:00 amRNSMajor Contract Placement
18th Oct 20242:03 pmRNSPDMR/PCA Shareholding
9th Oct 20247:00 amRNSCompletion of Sale of PMC Division
27th Sep 20243:40 pmRNSSale of PMC and Board Changes
20th Sep 20247:00 amRNSUpdate on Sale of PMC Division & Trading
25th Jun 20247:00 amRNS2024 Interim Results
21st Mar 202412:10 pmRNSResults of 2024 Annual General Meeting
14th Mar 20247:00 amRNSContract Placements and Update on Sale of PMC
14th Feb 20247:00 amRNSNotice of 2024 Annual General Meeting
30th Jan 20247:00 amRNS2023 Full-Year Results
16th Nov 20237:00 amRNSDebt Refinancing and Grant of Warrants
24th Oct 20237:00 amRNSDebt Refinancing - Agreement in Principle
9th Oct 20239:28 amRNSHolding(s) in Company
5th Oct 20233:56 pmRNSHolding(s) in Company
5th Oct 20233:52 pmRNSHolding(s) in Company
5th Oct 20232:38 pmRNSHolding(s) in Company
4th Oct 20233:10 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSPost-Close Update
11th Aug 20232:24 pmRNSHolding(s) in Company
27th Jun 20237:00 amRNS2023 Interim Results
13th Jun 202311:40 amRNSResult of General Meeting
26th May 202312:02 pmRNSHolding(s) in Company
23rd May 20237:30 amRNSRestoration - Pressure Technologies plc
23rd May 20237:05 amRNSConfirmation of Board Appointments
23rd May 20237:00 amRNS2022 Full-Year Results
27th Apr 202310:30 amRNSFurther Update on FY22 Annual Report & Accounts
3rd Apr 20237:30 amRNSSuspension - Pressure Technologies plc
31st Mar 20231:56 pmRNSResult of AGM
27th Mar 20237:05 amRNSMajor Order Placement
27th Mar 20237:00 amRNSUpdate on Annual Report and Accounts
21st Mar 20237:05 amRNSBoard Appointments
21st Mar 20237:00 amRNSUpdate on FY22 Audit, AGM & Current Trading
7th Mar 20237:00 amRNSNotice of AGM
6th Feb 20237:00 amRNSContract
17th Jan 20237:00 amRNSAppointment of Chief Financial Officer
21st Dec 202211:57 amRNSHolding(s) in Company
8th Dec 20227:58 amRNSHolding(s) in Company
7th Dec 20221:44 pmRNSHolding(s) in Company
2nd Dec 20221:20 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.